APA (7th ed.) Citation

DR, P., EP, J., JD, D., NA, V., NR, A., & IF, P. (2012). ABT-737 synergizes with bortezomib to induce apoptosis, mediated by Bid cleavage, Bax activation, and mitochondrial dysfunction in an Akt-dependent context in malignant human glioma cell lines. The Journal of pharmacology and experimental therapeutics, 341(3), 859. https://doi.org/10.1124/jpet.112.191536

Chicago Style (17th ed.) Citation

DR, Premkumar, Jane EP, DiDomenico JD, Vukmer NA, Agostino NR, and Pollack IF. "ABT-737 Synergizes with Bortezomib to Induce Apoptosis, Mediated by Bid Cleavage, Bax Activation, and Mitochondrial Dysfunction in an Akt-dependent Context in Malignant Human Glioma Cell Lines." The Journal of Pharmacology and Experimental Therapeutics 341, no. 3 (2012): 859. https://doi.org/10.1124/jpet.112.191536.

MLA (9th ed.) Citation

DR, Premkumar, et al. "ABT-737 Synergizes with Bortezomib to Induce Apoptosis, Mediated by Bid Cleavage, Bax Activation, and Mitochondrial Dysfunction in an Akt-dependent Context in Malignant Human Glioma Cell Lines." The Journal of Pharmacology and Experimental Therapeutics, vol. 341, no. 3, 2012, p. 859, https://doi.org/10.1124/jpet.112.191536.